Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Paul

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2020
Novel Mouse Model for Studying Hemostatic Function of Human PlateletsDavid S Paul, Wolfgang Bergmeier
American Journal of Physiology. Endocrinology and Metabolism|June 3, 2004
MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytesAnne W Harmon, David S Paul, Yashomati M Patel
Environmental Health Perspectives|May 20, 2011
Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat dietDavid S Paul, Felecia S Walton, R Jesse Saunders, et al.
The Biochemical Journal|September 17, 2003
Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytesDavid S Paul, Anne W Harmon, Courtney P Winston, et al.
Environmental Health Perspectives|May 24, 2007
Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acidDavid S Paul, Anne W Harmon, Vicenta Devesa, et al.
Archives of Toxicology|December 19, 2009
Metabolism of arsenic in human liver: the role of membrane transportersZuzana Drobná, Felecia S Walton, David S Paul, et al.
Toxicology and Applied Pharmacology|July 28, 2004
Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetesFelecia S Walton, Anne W Harmon, David S Paul, et al.
Thrombosis and Haemostasis|January 30, 2023
Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic CancerTomohiro Kawano, Yohei Hisada, Steven P Grover, et al.
Biochimica Et Biophysica Acta|March 18, 2014
Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycinDavid S Paul, Trisha J Grevengoed, Florencia Pascual, et al.
Toxicology and Applied Pharmacology|March 6, 2007
Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetesDavid S Paul, Araceli Hernández-Zavala, Felecia S Walton, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2020
Novel Mouse Model for Studying Hemostatic Function of Human PlateletsDavid S Paul, Wolfgang Bergmeier
American Journal of Physiology. Endocrinology and Metabolism|June 3, 2004
MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytesAnne W Harmon, David S Paul, Yashomati M Patel
Environmental Health Perspectives|May 20, 2011
Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat dietDavid S Paul, Felecia S Walton, R Jesse Saunders, et al.
The Biochemical Journal|September 17, 2003
Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytesDavid S Paul, Anne W Harmon, Courtney P Winston, et al.
Environmental Health Perspectives|May 24, 2007
Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acidDavid S Paul, Anne W Harmon, Vicenta Devesa, et al.
Archives of Toxicology|December 19, 2009
Metabolism of arsenic in human liver: the role of membrane transportersZuzana Drobná, Felecia S Walton, David S Paul, et al.
Toxicology and Applied Pharmacology|July 28, 2004
Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetesFelecia S Walton, Anne W Harmon, David S Paul, et al.
Thrombosis and Haemostasis|January 30, 2023
Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic CancerTomohiro Kawano, Yohei Hisada, Steven P Grover, et al.
Biochimica Et Biophysica Acta|March 18, 2014
Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycinDavid S Paul, Trisha J Grevengoed, Florencia Pascual, et al.
Toxicology and Applied Pharmacology|March 6, 2007
Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetesDavid S Paul, Araceli Hernández-Zavala, Felecia S Walton, et al.
Pageof 5